Toggle navigation
Home
Search
Services
Blog
Contact
About
Medications Development for Stimulant Dependence (MDS)
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
MRI-Guided miRNA Nanoparticle Delivery to Glioblastoma With Focused Ultrasound
Oral Microbiome and Periodontitis: A Prospective Study in Postmenopausal Women
Immunobiology of Viral Induced Tumors in Experimental Animals
Studies of Sensory-Motoneuron Contacts
Placental Immunoreactive Gnrh & Hcg Levels in Diabetic Pregnancy
Recently added grants:
Post-transcriptional Gene Regulation by EBV SM Protein.
Human siglec ligands control mast cell and eosinophil mediated inflammation
Role of p53 Missense Mutations on Tumorigenesis in Vivo
The role of butyrate-producing bacteria in CIMP colorectal cancer tumorigenesis
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses tohirsutinolides
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
N01DA38824-21-0-2
Application #
7581649
Study Section
Project Start
2003-01-17
Project End
2008-01-16
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 DA
Medications Development for Stimulant Dependence (MDS)
/ University of California Los Angeles
$223,660
NIH 2007
N01 DA
Medications Development for Stimulant Dependence (MDS)
Ling, Walter /
$1,202,203
NIH 2007
N01 DA
/
NIH 2007
N01 DA
Medications Development for Stimulant Dependence (MDS)
/
Comments
Be the first to comment on this grant